Replimune Group Gestione
Gestione criteri di controllo 2/4
Replimune Group Il CEO è Sush Patel, nominato in Apr2024, ha un mandato di meno di un anno. possiede direttamente 0.074% delle azioni della società, per un valore di $ 751.70K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.2 anni e 6.4 anni.
Informazioni chiave
Sush Patel
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | 0.07% |
| Durata media del management | 1.2yrs |
| Durata media del Consiglio di amministrazione | 6.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23
Replimune: Strong Data In A Highly Differentiated Space
Sep 03Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune: Continuing To Justify The Bear Thesis (For Now)
May 22Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer
Jan 23Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)
Dec 25Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Jan 06Replimune secures $200M term loan
Oct 07Replimune: Recent Developments Strengthen Bull Thesis
Aug 12Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Replimune Group GAAP EPS of -$0.78 misses by $0.15
Aug 04Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate
Jun 24We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate
Apr 04Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth
Dec 16Replimune: In The 'Buy Zone' Again
Oct 01Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Sep 02Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business
May 24Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic
Apr 30We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow
Feb 08Replimune Group EPS misses by $0.03
Feb 04Dosing underway in Replimune's early-stage cancer study with gene therapy
Jan 05Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$213m |
| Jun 30 2024 | n/a | n/a | -US$220m |
| Mar 31 2024 | n/a | n/a | -US$216m |
| Dec 31 2023 | n/a | n/a | -US$210m |
| Sep 30 2023 | n/a | n/a | -US$199m |
| Jun 30 2023 | n/a | n/a | -US$182m |
| Mar 31 2023 | US$3m | US$447k | -US$174m |
| Dec 31 2022 | n/a | n/a | -US$157m |
| Sep 30 2022 | n/a | n/a | -US$147m |
| Jun 30 2022 | n/a | n/a | -US$133m |
| Mar 31 2022 | US$7m | US$394k | -US$118m |
Compensazione vs Mercato: Dati insufficienti per stabilire se la retribuzione totale di Sush sia ragionevole rispetto ad aziende di dimensioni simili nel mercato US.
Compensazione vs guadagni: La retribuzione di Sush è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Sush Patel (53 yo)
less than a year
Mandato
US$2,595,003
Compensazione
Dr. Sushil Patel, also known as Sush,Ph D, is CEO & Director of Replimune Group, Inc. from April 1, 2024. Dr. Patel served as the Chief Commercial Officer at Replimune Group, Inc. since May 3, 2021 and ser...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 9.8yrs | US$6.02m | 1.86% $ 19.0m | |
| Chief Financial Officer | 1.2yrs | US$3.61m | 0.017% $ 177.5k | |
| Chief Medical Officer | 1.9yrs | US$2.45m | 0.017% $ 169.4k | |
| CEO & Director | less than a year | US$2.60m | 0.074% $ 751.7k | |
| Founder | no data | US$5.72m | 2.57% $ 26.2m | |
| Chief Accounting Officer & Treasurer | 1.5yrs | Nessun dato | 0.010% $ 104.8k | |
| Chief Commercial Officer | 1.9yrs | Nessun dato | 0.017% $ 177.7k | |
| Chief Manufacturing Officer & Framingham Site Head | less than a year | Nessun dato | Nessun dato |
1.2yrs
Durata media
53yo
Età media
Gestione esperta: Il team dirigenziale di REPL non è considerato esperto (durata media 1.2 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 9.8yrs | US$6.02m | 1.86% $ 19.0m | |
| CEO & Director | less than a year | US$2.60m | 0.074% $ 751.7k | |
| Founder | 9.8yrs | US$5.72m | 2.57% $ 26.2m | |
| Independent Director | 7.1yrs | US$362.60k | 0.0097% $ 99.5k | |
| Independent Non-Executive Director | 6.5yrs | US$355.10k | 0% $ 0 | |
| Independent Director | 4.6yrs | US$360.10k | 0% $ 0 | |
| Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | 7.3yrs | US$357.60k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$352.60k | 0% $ 0 | |
| Lead Independent Director | 6.4yrs | US$516.81k | 0% $ 0 | |
| Independent Director | 1.4yrs | US$667.97k | 0% $ 0 |
6.4yrs
Durata media
59yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di REPL sono considerati esperti (durata media dell'incarico 6.4 anni).